Skip to main content
. 2021 Apr 16;12:640297. doi: 10.3389/fphar.2021.640297

FIGURE 4.

FIGURE 4

Pre-treatment with AGNHW enhanced activation of GSK-3β/HO-1 pathway. Western blot analysis (A) and the normalized protein levels (B) of the indicated protein markers of the GSK-3β/HO-1 pathway in the infarct area of the ischemic cortex in MCAO rats with or without AGNHW pre-treatment. AGNHW pre-treatment significantly increased the ratio of p-GSK-3β(Ser9)/GSK-3β and the expression of HO-1 in the infarct area of MACAO rats. Full length blots are shown in Supplementary Figure S1. N = 4 rats per group. Data are means ± S.D. ## p < 0.01, compared with sham group; **p < 0.01, compared with vehicle group; b P<0.05, compared with AGNHW-M group.